View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Endo Pharmaceuticals settles lawsuit over unlawful marketing

No Comments
Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

US, Indian officials meet to discuss drug safety

No Comments
India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

No Comments
The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

No Comments
The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Israel's Teva to buy NuPathe for $144 million

No Comments
Pennsylvania-based NuPathe specializes in therapeutics for diseases of the central nervous system (CNS), including neurological and psychiatric disorders.
Read More

Novo Nordisk locked in legal battle over generic drug

No Comments
Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

No Comments
Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

US, European watchdogs join forces to regulate generic drugs

No Comments
The European Medicines Agency and the U.S. Food and Drug Administration have started a joint program for sharing information on bioequivalence studies required during the process of approval for generic drugs.
Read More

FDA tightens grip on Indian drug makers

No Comments
The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

Chinese pharma probe spreads to two Danish drug makers

No Comments
Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More